Yi-TsungLuMD(He/Him)
Oncology • Los Angeles, CAGenitourinary Oncology
Associate Medical Director, Seagen
Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2051 Marengo St
Los Angeles, CA 90033Phone+1 323-409-1000- Is this information wrong?
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2017 - 2020
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2017
Cedars-Sinai Medical CenterUrology Oncology Research Program, 2012 - 2014
National Taiwan University College of MedicineClass of 2011, MD
Certifications & Licensure
CA State Medical License 2017 - 2022
IL State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow Society of Translational Oncology, 2018
- 3x Best Show and Tail Presentation Stroger Hospital, 2015
- Finalist, Malaniak Award for Excellence Cedars-Sinai Medical Center, 2014
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsCell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.Yi-Tsung Lu, Melissa Plets, Gareth Morrison, Alexander T Cunha, Steven Y Cen, Suhn K Rhie, Kimberly D Siegmund, Siamak Daneshmand, David I Quinn, Joshua J Meeks, Seth ...> ;European Urology Oncology. 2023 Oct 1
- 6 citationsBladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time.Tong Xu, Jason A Junge, Alireza Delfarah, Yi-Tsung Lu, Cosimo Arnesano, Maheen Iqbal, Kevin Delijani, Tien-Chan Hsieh, Emmanuelle Hodara, Hemal H Mehta, Pinchas Cohen,...> ;Scientific Reports. 2022 Apr 1
- 7 citationsFOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.Yi-Tsung Lu, Tong Xu, Maheen Iqbal, Tien-Chan Hsieh, Zhifei Luo, Gangning Liang, Peggy J Farnham, Suhn K Rhie, Amir Goldkorn> ;Cancers. 2022 Mar 28
- Join now to see all
Abstracts/Posters
- Single-CTC whole genome sequencing in prostate cancer.Lu YT, Jiang R, Tseng HR, and Posadas EM, AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, San Diego, CA, 1/1/2014
- Single-CTC whole genome sequencing in prostate cancer.Lu YT, and Posadas EM, 5th Cedars-Sinai Medical Center Research Day, Los Angeles, CA, 1/1/2014
- Circulating Tumor Cells as a Surrogate Tissue Source for Whole Genome Sequencing in Prostate Cancer.Lu YT, Li B, Jiang R, Tseng HR, and Posadas EM, 10th World Congress on Urologic Research, Nashville, TN, 1/1/2013
- Join now to see all
Lectures
- Epigenomic profiling of plasma cell-free DNA (cfDNA) to predict bladder cancer recurrence after radical cystectomy.2019 ASCO Annual Meeting - 6/1/2019
- "Liquid biopsies and molecular profiling of cell-free DNA."Los Angeles, CA - 1/8/2018
- "Single-cell whole genome sequencing of CTCs in prostate cancer."Cedars-Sinai Medical Center, Los Angeles, CA - 1/29/2014
- Join now to see all
Grant Support
- Career Development AwardTower Cancer Research Foundation2018–2019
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
USC Norris Comprehensive Cancer CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
